Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3

被引:136
|
作者
Gui, Chunshan [1 ]
Miao, Yi [1 ]
Thompson, Lucas [1 ]
Wahlgren, Bret [1 ]
Mock, Melissa [3 ]
Stieger, Bruno [3 ]
Hagenbuch, Bruno [1 ,2 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Kansas Mason Canc Res Inst, Kansas City, KS 66103 USA
[3] Univ Zurich Hosp, Dept Med, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland
关键词
organic anion transporting polypeptide; hepatocyte; drug-drug interaction; nuclear receptor ligand;
D O I
10.1016/j.ejphar.2008.01.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pregnane X receptor is a ligand-activated transcription factor that is abundantly expressed in hepatocytes. Numerous drugs are pregnane X receptor ligands. To bind to their receptor they must cross the sinusoidal membrane. Organic anion transporting polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) are polyspecific transporters expressed at the sinusoidal membrane of human hepatocytes. They mediate transport of a variety of drugs including the pregnane X receptor ligands rifampicin and dexamethasone. To test whether additional pregnane X receptor ligands interact with OATP1B1 - and 1B3-mediated transport, we developed Chinese Hamster Ovary (CHO) cell lines stably expressing OATP1B1 or 1B3 at high levels. OATP1B1- and 1B3-mediated estradiol-17 beta-glucuronide uptake was inhibited by several pregnane X receptor ligands in a concentration dependent way. IC50 values for rifampicin, paclitaxel, mifepristone, and troglitazone were within their respective pharmacological free plasma concentrations. Kinetic analysis revealed that clotrimazole inhibits OATP1B1-mediated estradiol-17 beta-glucuronide transport with a K-i of 7.7 +/- 0.3 mu M in a competitive way. However, uptake of OATP1B3-mediated estradiol-17 beta-glucuronide was stimulated and this stimulation was due to an increased apparent affinity. Transport of estrone-3-sulfate was hardly affected while all other substrates tested were inhibited. Additional azoles like fluconazole, ketoconazole and miconazole did not stimulate OATP1B3-mediated estradiol-17 beta-glucuronide transport. In summary, these results demonstrate that pregnane X receptor ligands, by inhibiting or stimulating OATP-mediated uptake, can lead to drug-drug interactions at the transporter level. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 65
页数:9
相关论文
共 50 条
  • [41] Effect of Rifampin-Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist Selatogrel
    Schilling, Uta
    Dingemanse, Jasper
    Voors-Pette, Christine
    Romeijn, Christel
    Dogterom, Peter
    Ufer, Mike
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 886 - 890
  • [42] OATP1B1, OATP1B3, and MRP2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker
    Nakagomi-Hagihara, R
    Nakai, D
    Kawai, K
    Yoshigae, Y
    Tokui, T
    Abe, T
    Ikeda, T
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (05) : 862 - 869
  • [43] Further Characterization of the Electrogenicity and pH Sensitivity of the Human Organic Anion-Transporting Polypeptides OATP1B1 and OATP1B3
    Martinez-Becerra, Pablo
    Briz, Oscar
    Romero, Marta R.
    Macias, Rocio I. R.
    Perez, Maria J.
    Sancho-Mateo, Carlos
    Lostao, Maria P.
    Fernandez-Abalos, Jose M.
    Marin, Jose J. G.
    MOLECULAR PHARMACOLOGY, 2011, 79 (03) : 596 - 607
  • [44] Effect of repaglinide on OATP1B1- and OATP1B3-mediated transport
    König, J
    Bachmakov, I
    Fromm, MF
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 137 - 137
  • [45] Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy
    Huimin Wang
    Ziru Yan
    Minyue Dong
    Xiaojun Zhu
    Hanzhi Wang
    Zhengping Wang
    Archives of Gynecology and Obstetrics, 2012, 285 : 1535 - 1540
  • [46] CHARACTERIZATION OF THE TRANSCELLULAR TRANSPORT PROPERTIES OF OATP1B3 SUBSTRATES IN NEW VERSIONS OF DOUBLE TRANSFECTED MDCK II CELLS, OATP1B3/MDR1, OATP1B3/MRP2 AND OATP1B3/BCRP
    Saito, Asami
    Ishiguro, Naoki
    Maeda, Kazuya
    Kishimoto, Wataru
    Ebner, Thomas
    Roth, Willy
    Igarashi, Takashi
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2007, 39 : 168 - 169
  • [47] Interaction of Digitalis-Like Compounds with Liver Uptake Transporters NTCP, OATP1B1, and OATP1B3
    Gozalpour, Elnaz
    Greupink, Rick
    Wortelboer, Heleen M.
    Bilos, Albert
    Schreurs, Marieke
    Russel, Frans G. M.
    Koenderink, Jan B.
    MOLECULAR PHARMACEUTICS, 2014, 11 (06) : 1844 - 1855
  • [48] Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy
    Wang, Huimin
    Yan, Ziru
    Dong, Minyue
    Zhu, Xiaojun
    Wang, Hanzhi
    Wang, Zhengping
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (06) : 1535 - 1540
  • [49] Nostocyclopeptide-M1: A Potent, Nontoxic Inhibitor of the Hepatocyte Drug Transporters OATP1B3 and OATP1B1
    Herfindal, Lars
    Myhren, Lene
    Kleppe, Rune
    Krakstad, Camilla
    Selheim, Frode
    Jokela, Jouni
    Sivonen, Kaarina
    Doskeland, Stein O.
    MOLECULAR PHARMACEUTICS, 2011, 8 (02) : 360 - 367
  • [50] ARE OATP1B1, OATP2B1, OATP1B3 AND NTCP TRANSPORTERS EXCLUSIVELY EXPRESSED IN THE PLASMA MEMBRANE OF TRANSPORTER-EXPRESSING CELLS?
    Kumar, Vineet
    Tot Bui Nguyen
    Toth, Beata
    Juhasz, Viktoria
    Unadkat, Jashvant D.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S20 - S21